EGFR-induced cell migration is mediated predominantly by the JAK-STAT pathway in primary esophageal keratinocytes

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 287, Issue 6 50-6, 2004, Pages

  Andl, Claudia D ^a   Mizushima, Takaaki ^a   Oyama, Kenji ^a   Bowser, Mark ^a   Nakagawa, Hiroshi ^a   Rustgi, Anil K ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Akt; Cell migration; Epidermal growth factor receptor

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; INTERSTITIAL COLLAGENASE; JANUS KINASE; JANUS KINASE 2; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; PROTEIN KINASE B; STAT PROTEIN; STAT1 PROTEIN; STAT3 PROTEIN;

ARTICLE; CELL MIGRATION; COMPLEX FORMATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ESOPHAGUS; HUMAN; HUMAN CELL; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REACTOR CASCADE; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANTIBODIES, BLOCKING; BLOTTING, WESTERN; CELL LINE; CELL MEMBRANE; CELL MOVEMENT; CELL NUCLEUS; COLLAGEN; CYTOPLASM; DNA-BINDING PROTEINS; ENZYME INHIBITORS; ESOPHAGUS; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; KERATINOCYTES; MATRIX METALLOPROTEINASE 1; MICROSCOPY, CONFOCAL; PHOSPHORYLATION; PROTEIN TRANSPORT; PROTEIN-SERINE-THREONINE KINASES; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; STAT3 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TYRPHOSTINS;

EID: 9244264472     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.00253.2004     Document Type: Article

References (41)

1. Andl CD, Mizushima T, Nakagawa H, Oyama K, Harada H, Chruma K, Herlyn M, and Rustgi AK. Epidermal growth factor mediates increased cell proliferation, migration and aggregation in esophageal keratinocytes in vitro and in vivo. J Biol Chem 278: 1824-1830, 2003.
2. Aznavoorian S, Moore BA, Alexander-Lister LD, Hallit SL, Windsor LJ, and Engler JA. Membrane type I-matrix metalloproteinase-mediated degradation of type I collagen by oral squamous cell carcinoma cells. Cancer Res 61: 6264-6275, 2001.
3. Beccari S, Teixeira L, and Rorth P. The JAK/STAT pathway is required for border cell migration during Drosophila oogenesis. Mech Dev 111: 115-123, 2002.
4. Berclaz G, Altermatt HJ, Rohrbach V, Siragusa A, Dreher E, and Smith PD. EGFR dependent expression of STAT3 (but not STAT1) in breast cancer. Int J Oncol 19: 1155-1160, 2001.
5. Bromberg J. Stat proteins and oncogenesis. J Clin Invest 109: 1139-1142, 2002.
6. Bromberg J and Darnell JE. The role of STATs in transcripuonal control and their impact on cellular function. Oncogene 19: 2468-2478, 2000.
7. Bromberg JF, Fan Z, Brown C, Mendelsohn J, and Darnell JE Jr. Epidermal growth factor-induced growth inhibition requires Stat1 activation. Cell Growth Differ 9: 505-512, 1998.
8. Bromberg JF, Wrzeszczynska MH, Devgan G, Zhao Y, Pestelll RG, Albanese C, and Darnell JE Jr. Stat3 as an oncogene. Cell 98: 295-303, 1999.
9. Coffer PJ and Kruijer W. EGF receptor deletions define a region specifically mediating STAT transcription factor activation. Biochem Biophys Res Commun 210: 74-81, 1995.
10. David M, Wong L, Flavell R, Thompson SA, Wells A, Larner AC, and Johnson GR. STAT activation by epidermal growth factor (EGF) and amphiregulin. Requirement for the EGF receptor kinase, but not for tyrosine phosphorylation sites or JAK1. J Biol Chem 271: 9185-9188, 1996.
11. Firtel RA and Chung CY. The molecular genetics of chemotaxis: sensing and responding to chemoattractant gradients. Bioessays 22: 603-615, 2000.
12. Frank DA, Mahajan S, and Ritz J. Fludarabine-induced immunosuppression is associated with inhibition of STAT1 signaling. Nat Med 5: 444-447, 1999.
13. Funamoto S, Meili R, Lee S, Parry L, and Firtel RA. Spatial and temporal regulation of 3-phosphoinositides by PI3-kinase and PTEN mediates chemotaxis. Cell 109: 611-623, 2002.
14. Ghiglione C, Devergne O, Georgenthum E, Carballes F, Medioni C, Cerezo D, and Noselli S. The Drosophila cytokine receptor Domeless controls border cell migration and epithelial polarization during oogenesis. Development 129: 5437-5447, 2002.
15. Grandis JR, Drenning SD, Chakraborty A, Zhou MY, Zeng Q, Pitt AS, and Tweardy DJ. Requirement of Stat3 but not Stat1 activation for epidermal growth factor receptor-mediated cell growth in vitro. J Clin Invest 102: 1385-1392, 1998.
16. Grille SJ, Bellacosa A, Upson J, Klein-Szanto AJ, van Roy F, Lee-Kwon W, Donowitz M, Tsichlis PN, and Larue L. The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines. Cancer Res 63: 2172-2178, 2003.
17. Gururajan R, Lahti JM, Grenet J, Easton J, Gruber I, Ambros PF, and Kidd VJ. Duplication of a genomic region containing the Cdc2L1-2 and MMP21-22 genes on human chromosome 1p36.3 and their linkage to D1Z2. Genome Res 8: 929-939, 1999.
18. Higuchi M, Masuyama N, Fukui Y, Suzuki A, and Gotoh Y. Akt mediates Rac/Cdc42-regulated cell motility in growth factor-stimulated cells and in invasive PTEN knockout cells. Curr Biol 11: 1958-1962, 2001.
19. Horvath CM. STAT proteins and transcriptional responses to extracellular signals. Trends Biochem Sci 25: 496-450, 2000.
20. Hou SX, Zheng Z, Chen X, and Perrimon N. The Jak/STAT pathway in model organisms: emerging roles in cell movement. Dev Cell 3: 765-778, 2002.
21. Kijima T, Niwa H, Steinman RA, Drenning SD, Gooding WE, Wentzel AL, Xi S, and Grandis JR. STAT3 activation abrogates growth factor dependence and contributes to head and neck squamous cell carcinoma tumor growth in vivo. Cell Growth Differ 13: 355-362, 2002.
22. Kim D, Kim S, Koh H, Yoon S, Chung A, Cho KS, and Chung J. Akt/PKB promotes cancer cell invasion via increased motility and metalloproteinase production. FASEB J 15: 1953-1962, 2001.
23. Leaman DW, Pisharody S, Flickinger TW, Commane MA, Schlessinger J, Kerr IM, Levy DE, and Stark GR. Roles of JAKs in activation of STATs and stimulation of c-fos gene expression by epidermal growth factor. Mol Cell Biol 16: 369-375, 1996.
24. Llano E, Pendas AM, Freije JP, Nakano A, Knauper V, Murphy G, and Lopez-Otin C. Identification and characterization of human MT5-MMP, a new membrane-bound activator of progelatinase is overexpressed in brain tumors. Cancer Res 59: 2570-2576, 1999.
25. Merlot S and Firtel RA. Leading the way: directional sensing through phosphatidylinositol 3-kinase and other signaling pathways. J Cell Sci 116: 3471-3478, 2003.
26. Meydan N, Grunberger T, Dadi H, Shahar M, Arpaia E, Lapidot Z, Leeder JS, Freedman M, Cohen A, Gazit A, Levitzki A, and Roifman CM. Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor. Nature 379: 645-648, 1996.
27. Mohanty S, Jermyn KA, Early A, Kawata T, Aubry L, Ceccarelli A, Schaap P, Williams JG, and Firtel RA. Evidence that the Dictyostelium Dd-STATa protein is a repressor that regulates commitment to stalk cell differentiation and is also required for efficient chemotaxis. Development 126: 3391-3405, 1999.
28. Nguyen H, Ramana CV, Bayes J, and Stark GR. Roles of phosphatidylinositol 3-kinase in interferon-γ-dependent phosphorylation of STAT1 on serine 727 and activation of gene expression. J Biol Chem 276: 33361-33368, 2001.
29. O'Shea JJ, Gadina M, and Schreiber RD. Cytokine signaling in 2002: new surprises in the Jak/Stat pathway. Cell 109: 121-131, 2002.
30. Park BK, Zeng X, and Glazer RI. Aktl induces extracellular matrix invasion and matrix metalloproteinase-2 activity in mouse mammary epithelial cells. Cancer Res 61: 7647-7653, 2001.
31. Quelle FW, Thierfelder W, Witthuhn BA, Tang B, Cohen S, and Ihle JN. Phosphorylation and activation of the DNA binding activity of purified Stat1 by the Janus protein-tyrosine kinases and the epidermal growth factor receptor. J Biol Chem 270: 20775-20780, 1995.
32. Servant G, Weiner OD, Herzmark P, Balla T, Sedat JW, and Bourne HR. Polarization of chemoattractant receptor signaling during neutrophil chemotaxis. Science 287: 1037-1040, 2000.
33. Silver DL and Montell DJ. Paracrine signaling through the JAK/STAT pathway activates invasive behavior of ovarian epithelial cells in Drosophila. Cell 107: 831-841, 2001.
34. Sun Y, Cheung JM, Martel-Pelletier J, Pelletier JP, Wenger L, Altman RD, Howell DS, and Cheung HS. Wild type and mutant p53 differentially regulate the gene expression of human collagenase-3 (hMMP-13). J Biol Chem 275: 11327-11323, 2000.
35. Sun Y, Sun Y, Wenger L, Rutter JL, Brinckerhoff CE, and Cheung HS. p53 Down-regulates human matrix metalloproteinase-1 (collagenase-1) gene expression. J Biol Chem 274: 11535-11540, 1999.
36. Vincenti MP, Schroen DJ, Coon CI, and Brinckerhoff CE. v-src Activation of the collagenase-1 (matrix metalloproteinase-1) promoter through PEA3 and STAT: requirement of extracellular signal-regulated kinases and inhibition by retinoic acid receptors. Mol Carcinog 21: 194-204, 1998.
37. Weiner OD. Regulation of cell polarity during eukaryotic chemotaxis: the chemotactic compass. Curr Opin Cell Biol 14: 196-202, 2002.
38. Whiteman EL, Chen JJ, and Birnbaum MJ. Platelet-derived growth factor (PDGF) stimulates glucose transport in 3T3-L1 adipocytes overexpressing PDGF receptor by a pathway independent of insulin receptor substrates. Endocrinology 144: 3811-3820, 2003.
39. Xia L, Wang L, Chung AS, Ivanov SS, Ling MY, Dragoi AM, Platt A, Gilmer TM, Fu XY, and Chin YE. Identification of both positive and negative domains within the epidermal growth factor receptor COOH-terminal region for signal transducer and activator of transcription (STAT) activation. J Biol Chem 277: 30716-30723, 2002.
40. Xie B, Zhao J, Kitagawa M, Durbin J, Madri JA, Guan JL, and Fu XY. Focal adhesion kinase activates Stat1 in integrin-mediated cell migration and adhesion. J Biol Chem 276: 19512-19523, 2001.
41. Yahata Y, Shirakata Y, Tokumaru S, Yamasaki K, Sayama K, Hanakawa Y, Detmar M, and Hashimoto K. Nuclear translocation of phosphorylated STAT3 is essential for VEGF-induced human dermal microvascular endothelial cell migration and tube formation. J Biol Chem 278: 40026-40031, 2003.